|1.||Lacy, Jeffrey L: 1 article (02/2008)|
|2.||Dewhirst, Mark W: 1 article (02/2008)|
|3.||Vlahovic, Gordana: 1 article (02/2008)|
|4.||Hawk, Thomas C: 1 article (02/2008)|
|5.||Petry, Neil A: 1 article (02/2008)|
|6.||Sporn, Thomas A: 1 article (02/2008)|
|7.||Wong, Terence Z: 1 article (02/2008)|
|8.||Shafaii, Kamaleddin: 1 article (01/2007)|
|9.||Kamrani, Yousef Yari: 1 article (01/2007)|
|10.||Jalilian, Amir Reza: 1 article (01/2007)|
01/01/1994 - "However, an excellent linear correlation exists between tumor perfusion calculated from [62Cu]Cu-PTSM data and tumor perfusion measured with 85Sr-microspheres (r = 0.94 for 80 samples), suggesting that [62Cu]Cu-PTSM may be useful as a radiopharmaceutical for PET studies of tumor perfusion."
10/01/1999 - "Cu-PTSM and its derivatives are considered to be used as a marker for microsome/cytosol redox ability in PET oncology, although the physiological role of the redox enzyme system in tumor cells has not been clarified. "
10/01/1999 - "On the other hand, Cu-PTSM was not reduced in tumor mitochondria. "
10/01/1999 - "To clarify the retention mechanism of a PET imaging agent Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-62-PTSM) in tumor cells, reductive metabolism of non-radioactive Cu-PTSM in five cultured tumor cell lines, a tumor specimen and non-tumor tissues in vitro was evaluated by electron spin resonance spectrometry (ESR). "
02/01/1995 - "Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging."
|2.||Soft Tissue Neoplasms
01/01/2007 - "[(64)Cu]-PTSM was prepared on a radiopharmaceutical scale using readily available zinc-68, with high quality and was shown to possess application in the therapy and/or imaging of fibrosarcoma."
01/01/2007 - "[(64)Cu]-PTSM was prepared using in-house made PTSM ligand and [(64)Cu]cuprous acetate and injected to fibrosarcoma-bearing mice. "
01/01/2007 - "In this study, a simple production method and tumor accumulation of [(64)Cu]-PTSM in fibrosarcoma-bearing mice were reported. "
|4.||Chromosome Aberrations (Chromosome Abnormalities)
01/01/2006 - "This study aims to clarify the enhancement effect on chromosomal aberrations via selective energy absorption by Cu atoms in cultured bone cancer cells with non-labelled Cu-pyruvaldehyde-bis(N(4)-methylsemicarbazone) (Cu-PTSM) and monochromatic X rays. "
01/01/2006 - "Enhancement of chromosomal aberrations in tumor cells with a non-labeled Cu-PTSM and irradiation with Cu K-shell monochromatic X rays."
|5.||Bone Neoplasms (Bone Cancer)
|1.||copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)
|4.||Glutathione (Reduced Glutathione)